GSE119424 GSE120214 TBXT brachyury inhibition 5 v 3 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_up.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

Pvt1 oncogene

Gene

PAX8 antisense RNA 1

Gene

long intergenic non-protein coding RNA 511

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

long intergenic non-protein coding RNA 707

Gene

NmrA like redox sensor 2, pseudogene

Gene

long intergenic non-protein coding RNA 294

Gene

NINJ2 antisense RNA 1



  • Gene

    PAX8 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    long intergenic non-protein coding RNA 707


  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    long intergenic non-protein coding RNA 294


  • Gene

    NINJ2 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.